Superficial Electron Therapy for Non-Melanoma Skin Cancer Precise Non-Invasive Treatment of Skin Cancer — Now, IntraOp is brining electron therapy to dermatology clinics—unlocking the promise of non-surgical treatment for non-melanoma skin cancers. Precise Non-Invasive Treatment of Skin Cancer — Now, IntraOp is brining electron therapy to dermatology clinics—unlocking the promise of non-surgical treatment for non-melanoma skin cancers. expand your armamentarium expand your armamentarium setREVStartSize({c: 'rev_slider_7_1',rl:[1240,1024,778,480],el:[700],gw:[1170],gh:[700],type:'hero',justify:'',layout:'fullwidth',mh:"700"});if (window.RS_MODULES!==undefined && window.RS_MODULES.modules!==undefined && window.RS_MODULES.modules["revslider71"]!==undefined) {window.RS_MODULES.modules["revslider71"].once = false;window.revapi7 = undefined;if (window.RS_MODULES.checkMinimal!==undefined) window.RS_MODULES.checkMinimal()}

Accelerating the Cure

IntraOp is the leading innovator of electron therapy devices for treating cancer. IntraOp’s compact and mobile linear accelerators enable oncologists to deliver effective, precise, and affordable radiation therapy at the point of care. The Mobetron is the most comprehensive electron therapy linear accelerator system with applications in intraoperative radiotherapy (IORT) and non-invasive treatment of skin cancer. Our technology unlocks new treatment options for patients and increases the accessibility of effective treatment. Leading oncologists, hospitals, and research centers all over the world utilize IntraOp’s products to improve patient care.

The IntraOp Mobetron is the only electron UHDR device approved for FLASH clinical trials.*

Precision Treatment in Microseconds

IntraOp is the first to provide ultra-high dose rate (UHDR) electron therapy for preclinical investigation of FLASH on an established clinical platform.

Why IntraOp for FLASH?
• Approved for trials
• Platform stablity
• Simplicity of electrons
• Dynamic pulse modulation
• Larger clinical volumes
• Proven clinical platform

FLASH RADIOTHERAPY
Pancreatic cancer treatment with electron IORT

Treat the Untreatable

Pancreatic cancer remains a lethal malignancy, and yet recent studies reveal that the precision of electron-based IORT with Mobetron delivers greater control. And therefore a greater advantage for more PDAC patients.

Why IntraOp for Pancreatic Cancer?
• Treat more patients
• Higher median survival
• Greater local control
• Equivalent post-op complications
• No increase in readmission

PANCREATIC CANCER
Electron Therapy for Skin Cancer

Electron Therapy for Skin Cancer

IntraOp provides a convenient, non-invasive alternative to surgery. Electron therapy enables patients to keep living their active lives with little to no recovery time.

Why IntraOp for Non-melanoma Skin Cancer?
• Compact design
• Greater precision
• Enhanced productivity
• Excellent cosmesis
• No scarring
• Lower cost of ownership

SKIN CANCER

Innovation: Let us introduce you to Mobetron.

Since 1997, the Mobetron continues to transform cancer treatment. The advantages extend from the hospital, to physician and patient.

Learn More

Technology: Why IORT with electrons?

For starters, portability. A self-shielded LINAC meant safe radiation could be brought to the operating room and in turn, to the patient.

Learn More

Locations: Where in the world is Mobetron?

Mobetron is closer than you think. More than forty units treating patients in the world's leading cancer centers. And counting.

Learn More

Contact: Let's work together. Wherever.

By now, you know the advantages of Mobetron and electron IORT. The next step is worth discussing. Let's talk about it.

Learn More